CWM
MXCT icon

Cabot Wealth Management’s MaxCyte MXCT Stock Holding History

Cabot Wealth Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Hold
88,623
– – 0.01% 142
2026
Q1 		$62.3K Hold
88,623
– – 0.01% 139
2025
Q4 		$137K Buy
+88,623
New +$142K 0.02% 138

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Cabot Wealth Management's MXCT Position: Q2 2026 in Review

Cabot Wealth Management held its MaxCyte (MXCT) position steady in Q2 2026 at 88,623 shares worth $109K. The position accounts for 0.01% of the portfolio, ranked #142.

Cabot Wealth Management first reported a position in MXCT in Q4 2025 and has held it in 3 quarters since. The position peaked at $137K in Q4 2025. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Cabot Wealth Management held 88,623 shares of MaxCyte worth $109K as of Q2 2026.
  • Cabot Wealth Management left its MaxCyte share count unchanged in Q2 2026.
  • MaxCyte made up 0.01% of Cabot Wealth Management's portfolio in Q2 2026, its #142 holding.
  • Cabot Wealth Management first reported a position in MaxCyte in Q4 2025 and has held it in 3 quarters since.
  • Cabot Wealth Management's MaxCyte position peaked at $137K in Q4 2025.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Cabot Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.